Disbrow Joshua R. 4/A
4/A · AYTU BIOPHARMA, INC · Filed Nov 28, 2022
Insider Transaction Report
Form 4/AAmended
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Purchase
Common Shares
2022-11-18$0.24/sh+222,000$52,614→ 1,119,506 total
4/A · AYTU BIOPHARMA, INC · Filed Nov 28, 2022
Common Shares